Randomized Trial of Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients Who Have Undergone Lamivudine/Adefovir Add-on Treatment
Phase of Trial: Phase IV
Latest Information Update: 12 Jan 2017
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Adefovir dipivoxil/lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 17 Apr 2016 Interim analysis (n=107) results presented at The International Liver Congress™ 2016
- 31 Mar 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2019 as reported by ClinicalTrials.gov record.
- 31 Mar 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2019 as reported by ClinicalTrials.gov record.